PAN Foundation and Patient Advocate Foundation announced a strategic merger in March 2026. As we prepare to launch the TotalAssist program on July 1, you can continue to use your grant and apply for grants with no interruptions to your funding and services. Beginning May 27, PAN will no longer offer a disease fund wait list. When it launches, TotalAssist grants will be offered first-come, first-served, and you can sign up to get notified immediately when your fund opens. Learn more and sign up today.
Diagnosis codes
ICD-10: D46.9, D46.1, D46.2, D46.20, D46.21, D46.22, D46.4, D46.A, D46.B, D46.C, D46.Z
About the disease
Myelodysplastic syndromes (MDS), also known as preleukemia, is a group of cancers in which bone marrow does not make enough healthy blood cells. MDS affects the nervous and immune systems, causing shortness of breath and fatigue.
Source: National Cancer Institute
More patient support
We encourage everyone, eligible or not, to sign up for FundFinder alerts and connect with other patient resources.
Get support services from our featured partner:
The Aplastic Anemia & MDS International Foundation provides education and support to patients and families living with aplastic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria, and related bone marrow failure diseases.
Help articles for providers
-
Subscribe to news
Sign up to receive PAN news, from helpful articles to action alerts.
Subscribe today -
-